On heels of Amgen lawsuit, FTC broadens investigation of PBMs
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
3 key biotech trends for 2023 and beyond
Teva is eyeing $2.5bn in Austedo sales in 2027
*please scroll down for all the latest news*
